Labio has launched its patented MIT[HD] technology, a delivery system aiming to redefine active ingredient efficacy in skin care. This innovation uses a multi-lamellar vesicle (MLV) structure to deliver high concentrations of active ingredients deeply into the skin — stably and with good performance, per the company.
Multilayered Delivery for Maximum Efficacy
The core of MIT[HD] technology is its structure, which combines:
- mannosyl erythritol lipid (MEL) derived from Pseudozyma sp. SY16
- with phospholipids.
According to Labio, this combination forms stable, multi-layered vesicles that mimic the skin's own structure, enhancing biocompatibility.
The ingredient's design enables it to carry high loads of both oil-soluble and water-soluble active ingredients, ensuring they reach their target within the skin for maximum impact. According to the company, the technology facilitates a multi-infusion mechanism for deeper penetration and prolonged release, enhancing absorption and extending the efficacy of skin care formulations.
High Stability and Eco-Friendly Innovation
A key benefit of the MIT[HD] system is reportedly its exceptional stability. The MEL tri-acyl components act as cross-linkers between the vesicle layers, creating a robust and resilient structure that protects the potency of the active ingredients. This ensures the formulation remains effective from production to application.
Furthermore, LABIO has prioritized sustainability in the development of this technology: the MEL is derived from a natural fermentation process, and the entire system is produced using a low-energy cold process.
This commitment to environmentally friendly practices positions the MIT[HD] technology as high-performing, sustainable innovation.
